tiprankstipranks

Mutya Harsch Insider Profile

4 Followers
Mutya Harsch, CLO and General Counsel at Foamix Pharma, holds 149.03K shares in VYNE Therapeutics (Ticker: VYNE), holds 96.47K shares in Foamix Pharma (Ticker: FOMX), holds ― shares in Satsuma Pharmaceuticals (Ticker: STSA).
tipranks
Mutya Harsch

Mutya Harsch
Foamix Pharma (FOMX)
CLO and General Counsel

Ranked #43,692 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+9.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$452K
100.00%
A breakdown of Mutya Harsch's holdings

Insider Roles

VYNE Therapeutics
(VYNE)
CLO AND GC
Roles that Mutya Harsch holds in companies

Most Profitable Insider Trade

Stock:
Foamix Pharma
(FOMX)
Rating:Informative Sell
Date:Apr 03, 2019 - Apr 03, 2020
Return:+23.70%
The most profitable trade made by Mutya Harsch

Mutya Harsch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FOMX
Foamix Pharma
Feb 24, 2020
Uninformative Buy
$288.45K
VYNE Therapeutics
Oct 02, 2024
CLO AND GC
Uninformative Sell
197.40
$451.55K
STSA
Satsuma Pharmaceuticals
List of latest transactions for each holding click on a transaction to see Mutya Harsch's performance on stock

Mutya Harsch insider profile FAQ

What is the percentage of profitable transactions made by Mutya Harsch?
The percentage of profitable transactions made by Mutya Harsch is 50%.
    What is the average return per transaction made by Mutya Harsch?
    The average return per transaction made by Mutya Harsch is 9.70%.
      What stocks does Mutya Harsch hold?
      Mutya Harsch holds: FOMX, VYNE, STSA stocks.
        What was Mutya Harsch’s latest transaction?
        Mutya Harsch latest transaction was an Uninformative Sell of $197.40.
          What was Mutya Harsch's most profitable transaction?
          Mutya Harsch’s most profitable transaction was an Informative Sell of FOMX stock on April 3, 2019. The return on the trade was 23.70%.
            What is Mutya Harsch's role in Foamix Pharma?
            Mutya Harsch's role in Foamix Pharma is CLO and General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.